SERIAL HIV SEROPREVALENCE SURVEYS - INTERPRETATION, DESIGN, AND ROLE IN HIV AIDS PREDICTION

被引:0
|
作者
ADES, AE
机构
关键词
HUMAN IMMUNODEFICIENCY VIRUS; SEROPREVALENCE; INCIDENCE; MODELING; SIMULATION; SURVEILLANCE; BACK-CALCULATION; PROGRESSION MARKERS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To examine the potential role of seroprevalence surveys in HIV epidemic analysis and prediction, seroprevalence was modeled in terms of age- and time-specific incidence, while taking account of the differential inclusion of infected and uninfected individuals in serosurveys. Differential inclusion had two components, one reflecting disease progression and the other background demographic factors that could change over time. Seroprevalence and progression marker data generated by simulated epidemics showed that age dependence in HIV incidence is a key factor in data interpretation. Time trends in seroprevalence are difficult to interpret, and incidence cannot be estimated from these data unless the effects of disease progression on inclusion are taken into account. Furthermore, changes in incidence could be hard to distinguish from changes in background differential inclusion, casting doubt on the value of smaller sentinel surveys. Uncertainty about differential inclusion severely limits the value of seroprevalence data in improving the precision of HIV/AIDS prediction. Progression marker data are even harder to interpret, since changes in incidence will have effects on the marker value distribution, the size, direction, and timing of which are highly age-dependent. Independent data on differential inclusion would enhance the value of data from seroprevalence surveys.
引用
收藏
页码:490 / 499
页数:10
相关论文
共 50 条
  • [1] HIV SEROPREVALENCE SURVEYS IN URUGUAY
    BERRIOLO, R
    COLISTRO, L
    ROSTKIER, J
    RIVAS, B
    ZESSLER, L
    AIDS, 1992, 6 (08) : 884 - 885
  • [2] DEFENDING HIV SEROPREVALENCE SURVEYS
    BUEHLER, JW
    PETERSEN, LR
    WARD, JW
    VALDISERRI, RO
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (02) : 319 - 320
  • [3] HIV seroprevalence surveys in Pakistan
    Kazi, BM
    Toor, ZI
    Ali, SM
    Iqbal, J
    Asif, A
    Yousaf, Z
    Haroona
    Ahmed, I
    Rashid, SA
    Shah, SA
    Mujeeb, SA
    Sumroo, M
    Kazi, FG
    Sadiq, M
    Haleem, M
    Ahmed, N
    Sheikh, NS
    Rashi, ZI
    Nathoneil, E
    Ashraf, M
    Raziq, F
    Khan, RM
    Barzgar, MA
    Zessler, L
    AIDS, 1996, 10 (08) : 926 - 927
  • [4] HIV SEROPREVALENCE SURVEYS - IMPETUS FOR PREVENTIVE ACTIVITIES
    NOVICK, LF
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1991, 81 : 61 - 63
  • [5] CANCER SURVEYS - CANCER, HIV AND AIDS
    BERAL, V
    JAFFE, H
    WEISS, R
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (08) : 1057 - 1058
  • [6] HIV SEROPREVALENCE SURVEYS IN DRUG-TREATMENT CENTERS
    JONES, TS
    ALLEN, DM
    ONORATO, IM
    PETERSEN, LR
    DONDERO, TJ
    PAPPAIOANOU, M
    PUBLIC HEALTH REPORTS, 1990, 105 (02) : 125 - 130
  • [7] IDUS AND HIV AIDS - EPIDEMIOLOGY, TRENDS AND RESEARCH METHODS - EPIDEMIOLOGY - HIV SEROPREVALENCE
    NEAIGUS, A
    DESJARLAIS, DC
    PAONE, D
    FRIEDMAN, SR
    DEREN, S
    WARD, TP
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 1993, 5 (04): : 508 - 514
  • [8] SAMPLE SIZES FOR NEEDLES IN A HAYSTACK - THE CASE OF HIV SEROPREVALENCE SURVEYS
    FRANK, JW
    COATES, RA
    BRANT, R
    GARBUTT, JM
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1990, 81 (01): : 50 - 52
  • [9] Implications of the HIV testing protocol for refusal bias in seroprevalence surveys
    Reniers, Georges
    Araya, Tekebash
    Berhane, Yemane
    Davey, Gail
    Sanders, Eduard J.
    BMC PUBLIC HEALTH, 2009, 9
  • [10] Implications of the HIV testing protocol for refusal bias in seroprevalence surveys
    Georges Reniers
    Tekebash Araya
    Yemane Berhane
    Gail Davey
    Eduard J Sanders
    BMC Public Health, 9